Rhizomucor and scedosporium infection post hematopoietic stem-cell transplant

Case Reports in Medicine

Volumn 2011, Issue , 2011, Pages

  Marques, Dânia Sofia ^a   Pinho Vaz, Carlos ^a   Branca, Rosa ^a   Campilho, Fernando ^a   Lamelas, Catarina ^b   Afonso, Luis Pedro ^c   Jacome, Manuel ^c   Breda, Eduardo ^a   Monteiro, Eurico ^a   Campos Júnior, António ^a  

^a Port Inst Oncol Francisco Gentil   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c Instituto Portuêgus de Oncologia Francisco Gentil   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; CLINDAMYCIN; CYCLOSPORIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

ADOLESCENT; ANTIBIOTIC THERAPY; APLASTIC ANEMIA; ARTICLE; BLINDNESS; CASE REPORT; COUGHING; DYSARTHRIA; DYSPNEA; ETHMOIDECTOMY; EXOPHTHALMOS; FEBRILE NEUTROPENIA; FEVER; FUNGUS CULTURE; GRAFT VERSUS HOST REACTION; HEADACHE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMIPARESIS; HEMOPTYSIS; HUMAN; LEUKOPENIA; LUNG LESION; MALE; MUCORMYCOSIS; NERVE COMPRESSION; ODYNOPHAGIA; OPTIC NERVE; OTALGIA; PERIORBITAL EDEMA; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PSEUDALLESCHERIASIS; RHIZOMUCOR; SCEDOSPORIUM; SINUSITIS; TONSILLITIS;

EID: 84875883536     PISSN: 16879627     EISSN: 16879635     Source Type: Journal    
DOI: 10.1155/2011/830769     Document Type: Article

References (30)

1. Wingard J. R., Leather H., A new era of antifungal therapy Biology of Blood and Marrow Transplantation 2004 10 2 73 90 (Pubitemid 38145862)
2. Marr K. A., Carter R. A., Boeckh M., Martin P., Corey L., Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors Blood 2002 100 13 4358 4366 (Pubitemid 35429674)
3. Neofytos D., Horn D., Anaissie E., Steinbach W., Olyaei A., Fishman J., Pfaller M., Chang C., Webster K., Marr K., Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of multicenter prospective antifungal therapy (PATH) alliance registry Clinical Infectious Diseases 2009 48 3 265 273
4. Kontoyiannis D. P., Lionakis M. S., Lewis R. E., Chamilos G., Healy M., Perego C., Safdar A., Kantarjian H., Champlin R., Walsh T. J., Raad I. I., Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases Journal of Infectious Diseases 2005 191 8 1350 1360
5. Rogers T. R., Treatment of zygomycosis: current and new options The Journal of Antimicrobial Chemotherapy 2008 61 i35 i40
6. Spellberg B., Walsh T. J., Kontoyiannis D. P., Edwards J. J., Ibrahim A. S., Recent advances in the management of mucormycosis: from bench to bedside Clinical Infectious Diseases 2009 48 12 1743 1751
7. Husain S., Muoz P., Forrest G., Alexander B. D., Somani J., Brennan K., Wagener M. M., Singh N., Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome Clinical Infectious Diseases 2005 40 1 89 99 (Pubitemid 40053464)
8. Cortez K. J., Roilides E., Quiroz-Telles F., Meletiadis J., Antachopoulos C., Knudsen T., Buchanan W., Milanovich J., Sutton D. A., Fothergill A., Rinaldi M. G., Shea Y. R., Zaoutis T., Kottilil S., Walsh T. J., Infections caused by Scedosporium spp Clinical Microbiology Reviews 2008 21 1 157 197
9. Johnson M. D., Perfect J. R., Combination antifungal therapy: what can and should we expect? Bone Marrow Transplantation 2007 40 4 297 306 (Pubitemid 47207744)
10. Meletiadis J., Mouton J. W., Meis J. F. G. M., Verweij P. E., In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates Antimicrobial Agents and Chemotherapy 2003 47 1 106 117 (Pubitemid 36070350)
11. Shand J. M., Albrecht R. M., Burnett H. F., Miyake A., Invasive fungal infection of the midfacial and orbital complex due to scedosporium apiospermum and mucormycosis Journal of Oral and Maxillofacial Surgery 2004 62 2 231 234 (Pubitemid 38140685)
12. Chaney S., Gopalan R., Berggren R. E., Pulmonary Pseudallescheria boydii infection with cutaneous zygomycosis after near drowning Southern Medical Journal 2004 97 7 683 687 (Pubitemid 38955846)
13. Grow W. B., Moreb J. S., Roque D., Manion K., Leather H., Reddy V., Khan S. A., Finiewicz K. J., Nguyen H., Clancy C. J., Mehta P. S., Wingard J. R., Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital Bone Marrow Transplantation 2002 29 1 15 19 (Pubitemid 34126493)
14. Trifilio S. M., Bennett C. L., Yarnold P. R., McKoy J. M., Parada J., Mehta J., Chamilos G., Palella F., Kennedy L., Mullane K., Tallman M. S., Evens A., Scheetz M. H., Blum W., Kontoyiannis D. P., Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy Bone Marrow Transplantation 2007 39 7 425 429 (Pubitemid 46487308)
15. Storek J., Wells D., Dawson M. A., Storer B., Maloney D. G., Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation Blood 2001 98 2 489 491
16. Jantunen E., Ruutu P., Niskanen L., Volin L., Parkkali T., Koukila-Khkl P., Ruutu T., Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients Bone Marrow Transplantation 1997 19 8 801 808 (Pubitemid 27207896)
17. Sullivan K. M., Dykewicz C. A., Longworth D. L., Boeckh M., Baden L. R., Rubin R. H., Sepkowitz K. A., Preventing opportunistic infections after hematopoietic stem cell transplantation: the Centers for Disease Control and Prevention, Infectious Diseases Society of America, and American Society for Blood and Marrow Transplantation Practice Guidelines and beyond Hematology 2001 392 421
18. Goodman J. L., Winston D. J., Greenfield R. A., Chandrasekar P. H., Fox B., Kaizer H., Shadduck R. K., Shea T. C., Stiff P., Friedman D. J., Powderly W. G., Silber J. L., Horowitz H., Lichtin A., Wolff S. N., Mangan K. F., Silver S. M., Weisdorf D., Ho W. G., A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation The New England Journal of Medicine 1992 326 13 845 851
19. Slavin M. A., Osborne B., Adams R., Levenstein M. J., Gary Schoch H., Feldman A. R., Meyers J. D., Bowden R. A., Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantationa prospective, randomized, double-blind study Journal of Infectious Diseases 1995 171 6 1545 1552
20. MacMillan M. L., Goodman J. L., DeFor T. E., Weisdorf D. J., Fluconazole to prevent yeast infections in bone marrow transplantation patients: a randomized trial of high versus reduced dose, and determination of the value of maintenance therapy American Journal of Medicine 2002 112 5 369 379 (Pubitemid 34246267)
21. Ullmann A. J., Lipton J. H., Vesole D. H., Chandrasekar P., Langston A., Tarantolo S. R., Greinix H., De Azevedo W. M., Reddy V., Boparai N., Pedicone L., Patino H., Durrant S., Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease The New England Journal of Medicine 2007 356 4 335 347 (Pubitemid 46148776)
22. Mousset S., Bug G., Heinz W. J., Tintelnot K., Rickerts V., Breakthrough zygomycosis on posaconazole prophylaxis after allogeneic stem cell transplantation Transplant Infectious Disease 2010 12 3 261 264
23. Winston D. J., Bartoni K., Territo M. C., Schiller G. J., Efficacy, safety, and breakthrough infections associated with standard long-lerm posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients Biology of Blood and Marrow Transplantation 2011 17 4 507 515
24. Kohl V., Mller C., Cornely O. A., Abduljalil K., Fuhr U., Vehreschild J. J., Scheid C., Hallek M., Rping M. J. G. T., Factors influencing pharmacokinetics of prophylactic posaconazole in patients undergoing allogeneic stem cell transplantation Antimicrobial Agents and Chemotherapy 2010 54 1 207 212
25. Reichenberger F., Habicht J. M., Gratwohl A., Tamm M., Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients European Respiratory Journal 2002 19 4 743 755 (Pubitemid 34285172)
26. Almyroudis N. G., Sutton D. A., Fothergill A. W., Rinaldi M. G., Kusne S., In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents Antimicrobial Agents and Chemotherapy 2007 51 7 2587 2590 (Pubitemid 47047341)
27. Page R. L., Schwiesow J., Hilts A., Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature Pharmacotherapy 2007 27 2 290 298 (Pubitemid 46214589)
28. Ibrahim A. S., Bowman J. C., Avanessian V., Brown K., Spellberg B., Edwards J. E., Douglas C. M., Caspofungin inhibits Rhizopus oryzae 1,3- -D-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis Antimicrobial Agents and Chemotherapy 2005 49 2 721 727 (Pubitemid 40175685)
29. John B. V., Chamilos G., Kontoyiannis D. P., Hyperbaric oxygen as an adjunctive treatment for zygomycosis Clinical Microbiology and Infection 2005 11 7 515 517 (Pubitemid 40895150)
30. Reed C., Ibrahim A., Edwards J. E., Walot I., Spellberg B., Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis Antimicrobial Agents and Chemotherapy 2006 50 11 3968 3969 (Pubitemid 44684931)